ADD-ON LEVETIRACETAM IN CHILDREN WITH REFRACTORY EPILEPSY: A SYSTEMATIC REVIEW

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

ABBASKHANIAN ALI; SHAHMOHAMMADI SOHEILA

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: Journal of Pediatrics Review Year:2016 | Volume:4 | Issue:2 Page(s): 0-0

Download Full-Text

View:

Download:

Cites:

Information Journal Paper

Title

ADD-ON LEVETIRACETAM IN CHILDREN WITH REFRACTORY EPILEPSY: A SYSTEMATIC REVIEW

Author(s)

ABBASKHANIAN ALI | SHAHMOHAMMADI SOHEILA | Issue Writer Certificate

Keywords

LEVETIRACETAM

EPILEPSY

NEW ANTIEPILEPTIC DRUG

CHILDHOOD REFRACTORY EPILEPSY

Abstract

Context: Recently, newanti-epileptic drugs are marketed to be used as an add-on to the traditional drugs in children with refractory EPILEPSY. LEVETIRACETAM is a second-generation of new anti-epileptic drugs with unknown precise mechanism of action in brain and synaptic vesicle in children with drug resistant EPILEPSY. Herein, the efficacy and safety of add-on LEVETIRACETAM in children with refractory EPILEPSY is reviewed.Evidence Acquisition: A literature review was performed on efficacy and safety of add-on LEVETIRACETAM in children with refractory EPILEPSY using international databases with the following terms: LEVETIRACETAM, refractory EPILEPSY, drug resistant EPILEPSY, seizures/epilepsy, children/pediatric. All articles related to add-on LEVETIRACETAM in children with refractory EPILEPSY written in English and published from 2000 to 2015 were included. The title and abstracts of 542 articles were assessed, of which, 488 were excluded.The full texts of the other 54 articles were assessed for relevance.Results: Of the nine eligible articles, 1036 patients aged18 years were identified. Male patients (52%) were more prominent than female ones. Five articles reported that LEVETIRACETAM therapy appeared more effective against localization-related than generalized EPILEPSY. The dosage of LEVETIRACETAM ranged from 6 to 70 mg/kg/day, with a mean of 43.2 mg/kg/day based on the mean doses reported by four of nine reviewed articles. The mean duration of follow-up was 39 weeks (ranging from 8 - 144 weeks). Administration of LEVETIRACETAM was effective in 42.24% of the patients (responders with>50% decrease in seizure frequency), of whom 11.8% had become seizure free. The mean number of anti-epileptic drugs tried before introducing LEVETIRACETAM treatment was 4.4 (ranging 1 - 20). The most frequent side effects were psychological and behavioral changes (11.1%), followed by agitation (9.2%) and sleep disturbances (6.7%).Conclusions: The current review demonstrated that LEVETIRACETAM, as an add-on therapy, is an effective and well-tolerated antiepileptic drug, associated with reversible and no serious side effects, to control seizure frequency of childhood refractory EPILEPSY.

Cites

No record.

References

No record.

Cite

APA: Copy

ABBASKHANIAN, ALI, & SHAHMOHAMMADI, SOHEILA. (). . , (), -. SID. https://sid.ir/paper/341232/en

Vancouver: Copy

ABBASKHANIAN ALI, SHAHMOHAMMADI SOHEILA. . [Internet]. ;():-. Available from: https://sid.ir/paper/341232/en

IEEE: Copy

ALI ABBASKHANIAN, and SOHEILA SHAHMOHAMMADI, “,” , vol. , no. , pp. –, , [Online]. Available: https://sid.ir/paper/341232/en

Related Journal Papers